Last reviewed · How we verify

NCT07292363

Inflammation-Related Endothelial Barrier Dysfunction in Patients With Apical Periodontitis

Completed Last updated 31 December 2025
What this trial tests

trial testing Apical lesions cure in Apical Periodontitis in 45 participants. Completed in 16 October 2025.

Timeline
9 February 2021
Primary endpoint
30 April 2022
16 October 2025

Quick facts

Lead sponsorUniversity of Turin, Italy
StatusCompleted
Study typeOBSERVATIONAL
Enrollment45
Start date9 February 2021
Primary completion30 April 2022
Estimated completion16 October 2025
Sites2 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Turin, Italy

Who can join

Adults 25 to 55, any sex, with Apical Periodontitis or Healhty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Inflammation is a common factor in chronic periodontitis and systemic diseases. However, to date, there is no scientific evidence supporting a causal effect of inflammation caused by apical periodontitis on endothelial barrier dysfunction. A case-control study was designed to evaluate serum levels of endothelial barrier dysfunction factors in a sample of healthy patients aged 25 to 55, with or without apical periodontitis, before endodontic treatment and 6 and 12 months after treatment. The aim of this study is to investigate the potential relationship between the presence of chronic endodontic lesions and inflammation-related alterations of the endothelial barrier that may compromise its integrity, as well as to determine whether endodontic treatment can reduce these factors, thereby preventing changes in endothelial permeability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Apical Periodontitis

Currently open trials in the same condition.

Other University of Turin, Italy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07292363.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing